Back to search

Canada· CA-DIN-01953583

PHENYLEPHRINE HYDROCHLORIDE INJECTION USP

A phenylephrine product containing phenylephrine (phenylephrine hydrochloride), registered in Canada by SANDOZ CANADA INCORPORATED. The same ATC class is registered in 15 of our 19 countries.

ATC C01CA06

Checked against Health Canada Drug Product Database (Canada) on

Informational only — not a medical device.

SOURCE REGISTER · CAHealth Canada Drug Product Database (Ca…normalisedPHENYLEPHRINE HYDROCHLORIDE INJECTION…ATCC01CA06REGISTER NO.CA-DIN-01953583PACKS LISTED0CHECKEDOctober 1, 2026

Where it is registered

Phenylephrine is registered in 15 of 19 countries.

Countries holding a registration under ATC C01CA06 (phenylephrine), each read from that country’s own register.

  • This record: Canada, from Health Canada Drug Product Database (Canada)
  • 8 of them publish a price we can compare per daily dose

Phenylephrine · ATC C01CA06

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Health Canada Drug Product Database (Canada)
Active substance
PHENYLEPHRINE (PHENYLEPHRINE HYDROCHLORIDE)
Manufacturer
SANDOZ CANADA INCORPORATED
Country
Canada (CA)
ATC code
C01CA06
ATC class
Phenylephrine
Defined daily dose
4 mg, P
Reimbursed
Not published by this register
Source register
Health Canada Drug Product Database (Canada)
Last checked
October 1, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

196 interactions on record for phenylephrine.

Graded by severity as the source publishes them — 28 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Phenylephrine · interactions on record

196 records

  • 28 severe
  • 166 moderate
  • 2 minor

Most severe, free to view

  • MethylergometrineG02AB01severe
  • ErgometrineG02AB03severe
  • LinezolidJ01XX08severe
  • ProcarbazineL01XB01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Health Canada Drug Product Database (Canada). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e506b38a-7740-4548-aa79-1255eba7c483
GET /v1/drugs/e506b38a-7740-4548-aa79-1255eba7c483?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "din": "01953583",
  "form": "LIQUID",
  "class": "Human",
  "routes": [
    "INTRAVENOUS",
    "INTRAMUSCULAR",
    "SUBCUTANEOUS"
  ],
  "source": "health_canada_dpd",
  "status": "MARKETED",
  "atc_raw": "C01CA06",
  "schedule": [
    "Ethical"
  ],
  "drug_code": "12889",
  "strengths": [
    "10 MG"
  ],
  "ahfs_class": null,
  "substances": [
    "PHENYLEPHRINE (PHENYLEPHRINE HYDROCHLORIDE)"
  ],
  "product_categorization": null
}

See everything about phenylephrine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.